Nanovision Debuts Phased-Array CT System at China International Supply Chain Expo, Files IPO Prospectus

(Source: Economic Daily)

Source: Economic Daily

From June 22 to 26, the 4th Chain Expo was held in Beijing. Nanovision made its debut at the expo with its phased-array CT system, leveraging the platform effect of the Chain Expo to comprehensively showcase its latest advancements in the field of high-end medical equipment.Snibetransform outcomes, further strengthen cooperation with global industrial and supply chain partners, and jointly promote the development and improvement of the next-generation high-end medical equipment industry ecosystem.

Founded in 2014, Nanovision is a high-tech enterprise dedicated to the research and development, manufacturing, sales, and service of phased-array CT systems and their core components. According to reports, unlike traditional CT scanners that rely on high-speed mechanical rotation for data acquisition, phased-array CT innovatively employs X-ray source arrays and detector arrays for electronic scanning. This represents a generational leap from “mechanical rotation” to “electronic scanning,” enabling not only higher-resolution images with greater detail depth of human tissue structures but also improved temporal consistency in imaging. This advancement opens up more efficient and safe pathways for refined disease assessment and precision medicine. Meanwhile, as medical imaging evolves toward digitalization and intelligence, the high-information-density image data generated by phased-array CT provides a richer data foundation for the innovative application of new technologies, such as artificial intelligence, in the healthcare sector.

Li Yunxiang, Founder, CEO, and President of Nanovision, stated that every fundamental breakthrough in medical imaging technology will have a profound impact on global public health. The Chain Expo is not only a platform for showcasing innovations but also a bridge linking global innovation resources. “We hope to seize this opportunity to comprehensively advance the deployment and application of phased-array CT across multiple centers and scenarios worldwide, and deepen collaborative innovation with global medical institutions, research organizations, and industry partners.”

“The future of the medical equipment industry lies in the integration of the global ecosystem. The international expansion of cutting-edge medical innovations requires not only robust technological support but also high-standard international operations and supply chain collaboration,” said Yuan Li, Chief Operating Officer of Nanovision. The company looks forward to joining hands with research institutions, clinical hospitals, and upstream and downstream supply chain partners worldwide to promote high-level industrial cooperation, enabling China’s original high-end medical achievements to serve overseas medical institutions and global patients earlier and more safely. (Zhu Lin, Economic Daily reporter)